Progestogen esters

Jan 22, 2020

Theramex Acquires Commercial Rights for Oral Contraceptive Zoely

May 28, 2019

Better Adherence, Better Health: The Pillgo Places Biometric Analysis And Drug Interaction Alerts Into An Already Advanced Smart Pillbox

Mar 25, 2019

Slayback Pharma announces approval of Hydroxyprogesterone Caproate Injection, USP 250 mg/ 1 mL in a single-dose vial, generic equivalent of Makena® Injection 250 mg/ 1 mL

Jan 21, 2019

Slayback Pharma announces launch of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 mL in a multi-dose vial, the first generic equivalent of Makena® Injection 1,250 mg/ 5 mL multi-dose vial

Jan 02, 2019

Slayback Pharma announces FDA approval of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 mL in a multi-dose vial, the first generic equivalent of Makena® Injection 1,250 mg/ 5 mL multi-dose vial

Jan 02, 2019

Studies Find That Transgender Hormone Therapy Is Less Risky Than Birth Control Pills

Jun 28, 2018

American Regent Announces the FDA Approval of Hydroxyprogesterone Caproate Injection, USP; the First Preservative Free, AP Rated Generic to Makena®*(1)

Dec 04, 2017

Breckenridge Pharmaceutical, Inc. Announces Final Approval of its ANDA Megestrol Acetate Oral Suspension (Megace® ES)